NCT05047536 2025-12-19KZR-261 in Subjects With Advanced Solid MalignanciesKezar Life Sciences, Inc.Phase 1 Terminated61 enrolled 25 charts
NCT05109442 2025-08-20Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing CancersAffimed GmbHPhase 1/2 Terminated112 enrolled 28 charts